SCHEMBL7379475

SCHEMBL7379475

CCOC(=O)c1ncc2[nH]c3ccccc3c2c1C

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 16/20 0.73
▸ GABRG2 P18507 16/20 0.73
▸ GABRB3 P28472 16/20 0.73
▸ GABRA5 P31644 16/20 0.73
▸ GABRA3 P34903 16/20 0.73
▸ GABRA2 P47869 14/20 0.73
▸ GABRA6 Q16445 9/20 0.73
▸ GABRP O00591 8/20 0.73
▸ GABRD O14764 8/20 0.73
▸ GABRB1 P18505 8/20 0.73
▸ GABRB2 P47870 8/20 0.73
▸ GABRA4 P48169 8/20 0.73
▸ GABRE P78334 8/20 0.73
▸ GABRG1 Q8N1C3 8/20 0.73
▸ GABRG3 Q99928 8/20 0.73
▸ GABRQ Q9UN88 8/20 0.73
▸ MAPT P10636 4/20 0.65
▸ MEN1 O00255 2/20 0.65
▸ KMT2A Q03164 2/20 0.65
▸ TDP1 Q9NUW8 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7382514 0.91 GABRA1 (0.62) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL7378655 0.89 GABRA1 (0.59) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL7383298 0.88 GABRA1 (0.81) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL7379700 0.87 GABRA1 (0.59) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL7383426 0.86 GABRA1 (0.69) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL7381402 0.85 GABRA1 (0.67) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL7374994 0.85 GABRA1 (0.78) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL7379685 0.85 GABRA1 (0.61) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL10835134 0.85 GABRA1 (0.58) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL10379207 0.84 GABRA1 (1.00) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0030254-B1 BETA-CARBOLIN-3-CARBOXYLIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR THERAPEUTICAL USE SCHERING AKTIENGESELLSCHAFT (DE) 1984-10-31 — — EP claimed
US-4371536-A TRANQUILIZERS A/S FERROSAN (DK) 1983-02-01 — — US claimed
US-5010077-A Tranquilizers A/S FERROSAN (DK) 1991-04-23 — — US disclosed
US-4855295-A Tetrahydro-beta-carbolines, and their use as drugs SCHERING AKTIENGESELLSCHAFT (DE) 1989-08-08 — — US disclosed
EP-0110813-B1 PROCESS FOR PRODUCING BETA-CARBOLINE DERIVATIVES SCHERING AKTIENGESELLSCHAFT (DE) 1988-04-20 — — EP disclosed
US-4731365-A 5-aminoalkyl-beta-carboline derivatives, psycho tropic compositions and use SCHERING AKTIENGESELLSCHAFT (DE) 1988-03-15 — — US disclosed
US-4705856-A Process for producing β-carboline derivatives SCHERING AKTIENGESELLSCHAFT (DE) 1987-11-10 — — US disclosed
US-4623649-A PSYCHOPHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 1986-11-18 — — US disclosed
US-4600715-A CENTRAL NERVOUS SYSTEM SHERING AKTIENGESELLSCHAFT (DE) 1986-07-15 — — US disclosed
EP-0030254-B1 BETA-CARBOLIN-3-CARBOXYLIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR THERAPEUTICAL USE SCHERING AKTIENGESELLSCHAFT (DE) 1984-10-31 — — EP disclosed
EP-0110813-A2 Process for producing beta-carboline derivatives SCHERING AKTIENGESELLSCHAFT (DE) 1984-06-13 — — EP disclosed
US-4371536-A TRANQUILIZERS A/S FERROSAN (DK) 1983-02-01 — — US disclosed
EP-0030254-A1 Beta-carbolin-3-carboxylic acid derivatives, pharmaceutical compositions containing them and their therapeutical use SCHERING AKTIENGESELLSCHAFT (DE) 1981-06-17 — — EP disclosed
Send feedback